Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

702 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.
Feinberg JE, Hurwitz S, Cooper D, Sattler FR, MacGregor RR, Powderly W, Holland GN, Griffiths PD, Pollard RB, Youle M, Gill MJ, Holland FJ, Power ME, Owens S, Coakley D, Fry J, Jacobson MA. Feinberg JE, et al. Among authors: griffiths pd. J Infect Dis. 1998 Jan;177(1):48-56. doi: 10.1086/513804. J Infect Dis. 1998. PMID: 9419169 Clinical Trial.
The effect of valaciclovir on cytomegalovirus viremia and viruria detected by polymerase chain reaction in patients with advanced human immunodeficiency virus disease. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.
Griffiths PD, Feinberg JE, Fry J, Sabin C, Dix L, Gor D, Ansari A, Emery VC. Griffiths PD, et al. J Infect Dis. 1998 Jan;177(1):57-64. doi: 10.1086/513806. J Infect Dis. 1998. PMID: 9419170 Clinical Trial.
Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.
Emery VC, Sabin C, Feinberg JE, Grywacz M, Knight S, Griffiths PD. Emery VC, et al. Among authors: griffiths pd. J Infect Dis. 1999 Sep;180(3):695-701. doi: 10.1086/314936. J Infect Dis. 1999. PMID: 10438356 Clinical Trial.
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.
Whitley RJ, Jacobson MA, Friedberg DN, Holland GN, Jabs DA, Dieterich DT, Hardy WD, Polis MA, Deutsch TA, Feinberg J, Spector SA, Walmsley S, Drew WL, Powderly WG, Griffiths PD, Benson CA, Kessler HA. Whitley RJ, et al. Among authors: griffiths pd. Arch Intern Med. 1998 May 11;158(9):957-69. doi: 10.1001/archinte.158.9.957. Arch Intern Med. 1998. PMID: 9588429
Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study. European-Australian Acyclovir Study Group.
Youle MS, Gazzard BG, Johnson MA, Cooper DA, Hoy JF, Busch H, Ruf B, Griffiths PD, Stephenson SL, Dancox M, et al. Youle MS, et al. Among authors: griffiths pd. AIDS. 1994 May;8(5):641-9. doi: 10.1097/00002030-199405000-00010. AIDS. 1994. PMID: 8060544 Clinical Trial.
Herpesviruses and AIDS.
Griffiths PD. Griffiths PD. Scand J Infect Dis Suppl. 1996;100:3-7. Scand J Infect Dis Suppl. 1996. PMID: 9163021 Review.
702 results